Patent · US Active

Biomaterial

US8318902B2 · kind B2 · utility

1Cited by
1References
38Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 10, 2007
Grant dateNov 27, 2012
Priority date
Expiry dateFeb 16, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L27/56
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A process for the preparation of a composite biomaterial comprising: providing a first substantially solid component comprising one or more of collagen, a glycosaminoglycan, albumin, hyaluronan, chitosan, and synthetic polypeptides comprising a portion of the polypeptide sequence of collagen, and optionally an inorganic material, said component having at least a surface portion that is porous; providing a fluid composition comprising one or more of collagen, a glycosaminoglycan, albumin, hyaluronan, chitosan, and synthetic polypeptides comprising a portion of the polypeptide sequence of collagen, and a liquid carrier, and optionally an inorganic material; contacting said fluid composition with said porous surface portion of said first component; cooling said fluid composition to a temperature at which the liquid carrier transforms into a plurality of solid crystals or particles; removing at least some of the plurality of solid crystals or particles by sublimation and/or evaporation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.